𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Completeness and accuracy of registration of ovarian cancer in the cancer registry of Norway

✍ Scribed by Solveig Tingulstad; Tore Halvorsen; Jarle Norstein; Bjørn Hagen; Finn Egil Skjeldestad


Publisher
John Wiley and Sons
Year
2002
Tongue
French
Weight
111 KB
Volume
98
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Completeness of reporting and accuracy of the diagnosis of ovarian cancer from one health region in Norway to the Cancer Registry were examined. Data kept by the Cancer Registry were evaluated against discharge diagnosis data from all 8 hospitals in the health region during the period of 1987–1996. The assessment of the accuracy of the diagnosis recorded in the Cancer Registry was based on review of all medical records in the hospital setting and on slide review of all histologic diagnoses. The overall completeness of reporting ovarian cancer to the Cancer Registry was 99.6%. The organ specific completeness of registration of histologic verified ovarian cancer within the Cancer Registry was 95.3%; 0.9% was erroneously coded and 3.5% had their diagnosis changed to ovarian cancer at re‐evaluation. Of all ovarian cancer cases registered at the Cancer Registry, 91% had a primary histologic diagnosis. Among 591 cases identified with a histologic diagnosis in the Cancer Registry, the accuracy of the diagnosis was estimated at 92%. Coding errors were found in 2% of these cases, while in 6% of the cases it was not possible to reproduce the original diagnosis of ovarian cancer at re‐evaluation. In order to provide data of high quality for cancer surveillance a cancer registry needs several data providers, such as histopathologic laboratory reports and clinical reports. In addition, assessment of reported data through stringent quality assurance procedures within the registry are necessary for reaching a nearly 100% completeness of registration as found for ovarian cancer in the Cancer Registry of Norway. © 2002 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


ESTIMATING THE COMPLETENESS OF PREVALENC
✍ R. CAPOCACCIA; R. DE ANGELIS 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB 👁 1 views

Prevalence data provided by cancer registries are generally biased, since the patients that were diagnosed before the starting of the registry's activity cannot be included in the statistics. The relevance of this incompleteness bias is estimated in this paper. Incidence and relative survival are mo

Case completeness and data accuracy in t
✍ Kathleen K. Thoburn; Robert R. German; Mary Lewis; Phyllis “Janie” Nichols; Faru 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 2 views

## Abstract ## BACKGROUND. Issues of case completeness (CC) and data quality within the National Program of Cancer Registries (NPCR)‐Cancer Surveillance System (NPCR‐CSS) are assessed in part by the NPCR Technical Assistance and Audit Program (NPCR‐TAA). In addition, the NPCR Annual Program Evalua

Trends in the incidence of ovarian cance
✍ Tone Bjørge; Anders Engeland; Svein Hansen; Claes G. Tropé 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 165 KB 👁 2 views

the incidence rate and person-years in the cell. When age, birth cohort and time-period effects were all included in the model, the parameters were not uniquely defined (Clayton and Schifflers, 1987b). In this case, the effects of the first and the last periods were Contract grant sponsor: Norwegian